RAPT THERAPTICS - Stock Price History | RAPT

Historical daily share price chart and data for RAPT THERAPTICS since 2021 adjusted for splits. The latest closing stock price for RAPT THERAPTICS as of September 24, 2021 is 34.37.
  • The all-time high RAPT THERAPTICS stock closing price was 48.86 on January 27, 2020.
  • The RAPT THERAPTICS 52-week high stock price is 43.26, which is 25.9% above the current share price.
  • The RAPT THERAPTICS 52-week low stock price is 14.63, which is 57.4% below the current share price.
  • The average RAPT THERAPTICS stock price for the last 52 weeks is 26.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
RAPT THERAPTICS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 25.6841 29.8900 48.8600 11.8600 19.7500 -28.47%
2019 23.2541 12.7000 30.7800 12.3000 27.6100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.009B $0.005B
RAPT Therapeutics Inc. is a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for oncology and inflammatory diseases. The company's drug candidate consists of FLX475 for the treatment of tumors and RPT193, a CCR4 antagonist for allergic inflammatory disease. RAPT Therapeutics Inc. is based in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71